Emmaus Fumes After EMA Rejects Sickle Cell Drug Again

 
• By Kevin Grogan

The US firm has withdrawn its submission to get EU approval for Xyndari. After being turned down by the CHMP, Emmaus may try the decentralized approval procedure instead.

Tearing
Rip it up and start again: Emmaus looks at new option to get Xyndari approved • Source: Shutterstock

More from New Products

More from Scrip